摘要
目的评价联合应用溶栓治疗和血栓抽吸对ST段抬高型急性心肌梗死(AMI)患者急诊冠状动脉介入治疗(PCI)后无复流的影响。方法纳入2007-2010年在发病24h内成功进行急诊PCI的534例ST段抬高型AMI患者,分为4组:A组(n=260),未应用溶栓治疗和血栓抽吸;B组(n=96),进行溶栓治疗;C组(n=143),进行血栓抽吸;D组(n=35),联合应用溶栓治疗和血栓抽吸。收集所有患者的临床、冠状动脉造影和PCI相关资料以评价联合应用溶栓治疗和血栓抽吸对无复流的影响。结果在534例患者中,发生无复流138例(25.8%),A、B、C、D组无复流发生率分别为32.7%(85/260)、20.8%(20/96)、21.7%(31/143)和5.7%(2/35),各组间比较差异有统计学意义(P=0.009)。结论联合应用溶栓治疗和血栓抽吸可显著降低ST段抬高型AMI患者急诊PCI术后无复流发生率。
Objective To assess the effects of combined application of thrombolytic therapy and aspiration thrombectomy on no-reflow phenomenon in patients with ST-segment elevation acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PCI). Methods Five hundred and thirty four patients with ST-segment elevation AMI,admitted from 2007 to 2010 and successfully treated with primary angioplasty within 24 hours after the onset of AMI,were divided into 4 groups:A group (without thrombolytic therapy combined with aspiration thrombectomy treatment),B group (only thrombolytic therapy),C group (only aspiration thrombectomy) and D group (treated with thrombolytic therapy and aspiration thrombectomy). All clinical,angiographic and procedural data were collected. Multiple logistic regression analysis was used to identify the related predictors of the no-reflow phenomenon. Results The no-reflow phenomenon was found in 138 (25.8%) of 534 patients. The incidence of no-reflow phenomenon in A,B,C,and D group was 32.7% (85/260),20.8% (20/96),21.7% (31/143) and 5.7% (2/35) (P=0.009),respectively. Conclusion Combined application of thrombolytic therapy and aspiration thrombectomy may significantly decrease the incidence of no-reflow phenomenon in patients with ST-segment elevation AMI and treated with primary PCI.
出处
《解放军医学杂志》
CAS
CSCD
北大核心
2010年第6期729-732,共4页
Medical Journal of Chinese People's Liberation Army
基金
北京市科委支持计划项目(Z09050700620909)
关键词
心肌梗死
血管成形术
经腔
经皮冠状动脉
血栓溶解疗法
无复流
myocardial infarction
angioplasty
transluminal
percutaneous coronary
thrombolytic therapy
no-reflow